185 related articles for article (PubMed ID: 32385660)
1. HbA1c variability, in addition to mean HbA1c, predicts incident hip fractures in Chinese people with type 2 diabetes.
Lui DTW; Lee CH; Chan YH; Chow WS; Fong CHY; Siu DCW; Tse HF; Woo YC; Lam KSL
Osteoporos Int; 2020 Oct; 31(10):1955-1964. PubMed ID: 32385660
[TBL] [Abstract][Full Text] [Related]
2. Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study.
Li CI; Liu CS; Lin WY; Meng NH; Chen CC; Yang SY; Chen HJ; Lin CC; Li TC
J Bone Miner Res; 2015 Jul; 30(7):1338-46. PubMed ID: 25598134
[TBL] [Abstract][Full Text] [Related]
3. Association between glycemic control and hip fracture.
Puar TH; Khoo JJ; Cho LW; Xu Y; Chen YT; Chuo AM; Poh CB; Ng JM
J Am Geriatr Soc; 2012 Aug; 60(8):1493-7. PubMed ID: 22862735
[TBL] [Abstract][Full Text] [Related]
4. Different glycaemia-related risk factors for incident Alzheimer's disease in men and women with type 2 diabetes-A sex-specific analysis of the Hong Kong diabetes database.
Lee CH; Lui DTW; Cheung CYY; Woo YC; Fong CHY; Yuen MMA; Shea YF; Siu DCW; Chan KH; Chow WS; Lam KSL
Diabetes Metab Res Rev; 2021 Sep; 37(6):e3401. PubMed ID: 32870568
[TBL] [Abstract][Full Text] [Related]
5. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.
Segar MW; Patel KV; Vaduganathan M; Caughey MC; Butler J; Fonarow GC; Grodin JL; McGuire DK; Pandey A
Diabetes Care; 2020 Aug; 43(8):1920-1928. PubMed ID: 32540922
[TBL] [Abstract][Full Text] [Related]
6. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
7. Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.
Yoo JH; Kang M; Kim G; Hur KY; Kim JH; Sinn DH; Jin SM
J Diabetes Investig; 2021 Jul; 12(7):1252-1262. PubMed ID: 33135331
[TBL] [Abstract][Full Text] [Related]
8. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GYH; Jensen MB
Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007030. PubMed ID: 30995869
[TBL] [Abstract][Full Text] [Related]
9. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
[TBL] [Abstract][Full Text] [Related]
10. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
11. Visit-to-Visit Variability of Hemoglobin A
Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
[TBL] [Abstract][Full Text] [Related]
12. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
[No Abstract] [Full Text] [Related]
13. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture.
Paterni S; Okoye C; Calabrese AM; Niccolai F; Polini A; Caraccio N; Calsolaro V; Monzani F
Front Endocrinol (Lausanne); 2021; 12():770400. PubMed ID: 34867813
[TBL] [Abstract][Full Text] [Related]
15. Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c.
Lee ATC; Richards M; Chan WC; Chiu HFK; Lee RSY; Lam LCW
Age Ageing; 2019 Nov; 48(6):838-844. PubMed ID: 31574142
[TBL] [Abstract][Full Text] [Related]
16. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
[TBL] [Abstract][Full Text] [Related]
17. Glycated hemoglobin and incident type 2 diabetes in singaporean chinese adults: the Singapore Chinese health study.
Bancks MP; Odegaard AO; Koh WP; Yuan JM; Gross MD; Pereira MA
PLoS One; 2015; 10(3):e0119884. PubMed ID: 25775375
[TBL] [Abstract][Full Text] [Related]
18. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
19. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
Josse RG; Majumdar SR; Zheng Y; Adler A; Bethel MA; Buse JB; Green JB; Kaufman KD; Rodbard HW; Tankova T; Westerhout CM; Peterson ED; Holman RR; Armstrong PW;
Diabetes Obes Metab; 2017 Jan; 19(1):78-86. PubMed ID: 27607571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
